Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
TD-4208 (formerly GSK1160724)
print preview
bookmark
share with colleague
General Information
Company
Theravance Inc.
Description
Inhaled long-acting muscarinic antagonist (LAMA)
Molecular Target
Muscarinic receptor
Mechanism of Action
Muscarinic receptor antagonist
Latest Stage of Development
Phase II
Indication
Chronic obstructive pulmonary disease (COPD)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy